Search research articles
Contact Us
Filters
Showing results (101-110 of 286) with videos related to
Page
of 29
Sort By:
Clinical Chemistry
|
December 1, 1994
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression
M Winkler, B Ringe, J Baumann, et al.
Transplantation Proceedings
|
April 1, 1996
CyA-NOF for early oral CyA-based immunosuppression in patients after liver transplantation
A Kattner, M Winkler, K Oldhafer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 1, 1991
Coagulation disorder during liver transplantation
M Sato, B Nashan, B Ringe, et al.
Transplantation
|
January 1, 1988
Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation
W Kamiike, M Burdelski, G Steinhoff, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung
|
January 1, 1987
[Changes in MHC expression after orthoptic liver transplantation]
G Steinhoff, K Wonigeit, W Lauchart, et al.
Transplantation Proceedings
|
September 25, 2002
Graft rupture after living donor liver transplantation
B Ringe, F Braun, S Laabs, et al.
Der Pathologe
|
January 10, 2001
[Undifferentiated small-cell hepatoblastoma]
B Sattler, B Gunawan, T Lorf, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1994
Neurological examinations after liver transplantation concerning patients under corticosteroid immunosuppression and either FK 506 or cyclosporin
K Trocha, M Winkler, J Haas, et al.
Mycoses
|
July 8, 1999
Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation
T Lorf, F Braun, R Rüchel, et al.
Transplantation Proceedings
|
August 1, 1993
Angiography and vascular radiologic intervention before and after liver transplantation
A Chavan, J Harms, H Rosenthal, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 286) with videos related to
Sort By:
Page
of 29
Clinical Chemistry
|
December 1, 1994
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression
M Winkler, B Ringe, J Baumann, et al.
Transplantation Proceedings
|
April 1, 1996
CyA-NOF for early oral CyA-based immunosuppression in patients after liver transplantation
A Kattner, M Winkler, K Oldhafer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 1, 1991
Coagulation disorder during liver transplantation
M Sato, B Nashan, B Ringe, et al.
Transplantation
|
January 1, 1988
Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation
W Kamiike, M Burdelski, G Steinhoff, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung
|
January 1, 1987
[Changes in MHC expression after orthoptic liver transplantation]
G Steinhoff, K Wonigeit, W Lauchart, et al.
Transplantation Proceedings
|
September 25, 2002
Graft rupture after living donor liver transplantation
B Ringe, F Braun, S Laabs, et al.
Der Pathologe
|
January 10, 2001
[Undifferentiated small-cell hepatoblastoma]
B Sattler, B Gunawan, T Lorf, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1994
Neurological examinations after liver transplantation concerning patients under corticosteroid immunosuppression and either FK 506 or cyclosporin
K Trocha, M Winkler, J Haas, et al.
Mycoses
|
July 8, 1999
Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation
T Lorf, F Braun, R Rüchel, et al.
Transplantation Proceedings
|
August 1, 1993
Angiography and vascular radiologic intervention before and after liver transplantation
A Chavan, J Harms, H Rosenthal, et al.
Page
of 29